Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis

被引:181
作者
Mogi, M [1 ]
Otogoto, J
Ota, N
Togari, A
机构
[1] Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Nagoya, Aichi 4648650, Japan
[2] Matsumoto Dent Univ, Sch Dent, Dept Periodontol, Nagano 3990781, Japan
关键词
RANKL; osteoprotegerin; gingival crevicular fluid; periodontal disease;
D O I
10.1177/154405910408300216
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The receptor activator for NF-kappaB ligand (RANKL) plays an important role in osteoclast formation. A recent study with animal models suggests the involvement of RANKL in the pathogenesis of this periodontal disease. However, no one has examined the level of RANKL in the body fluid of human subjects. This communication reports on the in vivo concentrations of RANKL and the RANKL decoy receptor osteoprotegerin (OPG) in the gingival crevicular fluid (GCF) of periodontal subjects with severe, moderate, and mild forms of the disease. An increased concentration of RANKL and a decreased concentration of OPG were detected in GCF from patients with periodontitis (*p < 0.05 vs. control subjects). The ratio of the concentration of RANKL to that of OPG in the GCF was significantly higher for periodontal disease patients than for healthy subjects (*p < 0.01). Taken together, these data suggest that RANKL and OPG contribute to osteoclastic bone destruction in periodontal disease. Abbreviations: GCF, gingival crevicular fluid; IL, interleukin; OPG, osteoprotegerin; RANK-L, receptor activator for NF-kappaB ligand.
引用
收藏
页码:166 / 169
页数:4
相关论文
共 20 条
  • [1] Cimasoni G., 1983, Monogr Oral Sci, V12, pIII
  • [2] HOST RESPONSES IN PERIODONTAL-DISEASES - CURRENT CONCEPTS
    GENCO, RJ
    [J]. JOURNAL OF PERIODONTOLOGY, 1992, 63 (04) : 338 - 355
  • [3] The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
    Hofbauer, LC
    Khosla, S
    Dunstan, CR
    Lacey, DL
    Boyle, WJ
    Riggs, BL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) : 2 - 12
  • [4] Osteoclast differentiation factor in human osteosarcoma cell line
    Kinpara, K
    Mogi, M
    Kuzushima, M
    Togari, A
    [J]. JOURNAL OF IMMUNOASSAY, 2000, 21 (04): : 327 - 340
  • [5] Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
    Kong, YY
    Feïge, U
    Sarosi, I
    Bolon, B
    Tafuri, A
    Morony, S
    Capparelli, C
    Li, J
    Elliott, R
    McCabe, S
    Wong, T
    Campagnuolo, G
    Moran, E
    Bogoch, ER
    Van, G
    Nguyen, LT
    Ohashi, PS
    Lacey, DL
    Fish, E
    Boyle, WJ
    Penninger, JM
    [J]. NATURE, 1999, 402 (6759) : 304 - 309
  • [6] Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO
  • [7] 2-#
  • [8] Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    Lacey, DL
    Timms, E
    Tan, HL
    Kelley, MJ
    Dunstan, CR
    Burgess, T
    Elliott, R
    Colombero, A
    Elliott, G
    Scully, S
    Hsu, H
    Sullivan, J
    Hawkins, N
    Davy, E
    Capparelli, C
    Eli, A
    Qian, YX
    Kaufman, S
    Sarosi, I
    Shalhoub, V
    Senaldi, G
    Guo, J
    Delaney, J
    Boyle, WJ
    [J]. CELL, 1998, 93 (02) : 165 - 176
  • [9] Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease
    Mogi, M
    Otogoto, J
    Ota, N
    Inagaki, H
    Minami, M
    Kojima, K
    [J]. ARCHIVES OF ORAL BIOLOGY, 1999, 44 (06) : 535 - 539
  • [10] Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand:: Modulation of the expression by osteotropic factors and cytokines
    Nakashima, T
    Kobayashi, Y
    Yamasaki, S
    Kawakami, A
    Eguchi, K
    Sasaki, H
    Sakai, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (03) : 768 - 775